|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q104848570
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010751.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q104848570
|
|
035
|
|
|
‡a
(OCoLC)Q104848570
|
|
100
|
0 |
|
‡a
Ghanem Ghanem
‡9
en
‡9
nl
|
|
670
|
|
|
‡a
Author's A non-coding function of TYRP1 mRNA promotes melanoma growth.
|
|
670
|
|
|
‡a
Author's A therapeutic approach to perianal extramammary Paget's disease: topical imiquimod can be useful to prevent or defer surgery
|
|
670
|
|
|
‡a
Author's Chronic exposure to low-dose radiation at Chernobyl favours adaptation to oxidative stress in birds
|
|
670
|
|
|
‡a
Author's EORTC Melanoma Group achievements
|
|
670
|
|
|
‡a
Author's Evaluation of the serum L-dopa/L-tyrosine ratio as a melanoma marker
|
|
670
|
|
|
‡a
Author's Functional status and relationships of melanocortin 1 receptor signaling to the cAMP and extracellular signal-regulated protein kinases 1 and 2 pathways in human melanoma cells.
|
|
670
|
|
|
‡a
Author's GLI inhibitor GANT61 kills melanoma cells and acts in synergy with obatoclax.
|
|
670
|
|
|
‡a
Author's Has removal of excess cysteine led to the evolution of pheomelanin?
|
|
670
|
|
|
‡a
Author's HER4 and its cytoplasmic isoforms are associated with progression-free survival of malignant melanoma.
|
|
670
|
|
|
‡a
Author's Human melanoma cell migration along capillary-like structures in vitro: a new dynamic model for studying extravascular migratory metastasis
|
|
670
|
|
|
‡a
Author's Hypopigmenting agents: an updated review on biological, chemical and clinical aspects
|
|
670
|
|
|
‡a
Author's Imaging of tumour-induced osteomalacia using a gallium-68 labelled somatostatin analogue.
|
|
670
|
|
|
‡a
Author's MDM4 is a key therapeutic target in cutaneous melanoma
|
|
670
|
|
|
‡a
Author's Melanins and melanogenesis: from pigment cells to human health and technological applications
|
|
670
|
|
|
‡a
Author's Melanoma cell attachment, invasion, and integrin expression is upregulated by tumor necrosis factor alpha and suppressed by alpha melanocyte stimulating hormone
|
|
670
|
|
|
‡a
Author's Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres
|
|
670
|
|
|
‡a
Author's N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by 89Zr-Trastuzumab and 18F-FDG PET imaging
|
|
670
|
|
|
‡a
Author's New Drug Combination Strategies in Melanoma: Current Status and Future Directions.
|
|
670
|
|
|
‡a
Author's Overexpression of malignancy-associated laminins and laminin receptors by angiotropic human melanoma cells in a chick chorioallantoic membrane model
|
|
670
|
|
|
‡a
Author's p53 Reactivation by PRIMA-1(Met) (APR-246) sensitises (V600E/K)BRAF melanoma to vemurafenib.
|
|
670
|
|
|
‡a
Author's Pericyte-like location of GFP-tagged melanoma cells: ex vivo and in vivo studies of extravascular migratory metastasis
|
|
670
|
|
|
‡a
Author's Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells
|
|
670
|
|
|
‡a
Author's PRIMA-1 and PRIMA-1Met
|
|
670
|
|
|
‡a
Author's PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies
|
|
670
|
|
|
‡a
Author's Prominent role of cyclic adenosine monophosphate signalling pathway in the sensitivity of
|
|
670
|
|
|
‡a
Author's Prominent role of cyclic adenosine monophosphate signalling pathway in the sensitivity of (WT)BRAF/(WT)NRAS melanoma cells to vemurafenib.
|
|
670
|
|
|
‡a
Author's Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma
|
|
670
|
|
|
‡a
Author's Role of farnesoid X receptor
|
|
670
|
|
|
‡a
Author's Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts
|
|
670
|
|
|
‡a
Author's Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma
|
|
670
|
|
|
‡a
Author's Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: a rationale to combine targeted drugs based on protein expression inhibition profiles
|
|
670
|
|
|
‡a
Author's Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT.
|
|
670
|
|
|
‡a
Author's Survey on skin-lightening practices and cosmetics in Kigali, Rwanda
|
|
670
|
|
|
‡a
Author's The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts
|
|
670
|
|
|
‡a
Author's Toad Venom Antiproliferative Activities on Metastatic Melanoma: Bio-Guided Fractionation and Screening of the Compounds of Two Different Venoms
|
|
670
|
|
|
‡a
Author's Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab
|
|
670
|
|
|
‡a
Author's Tyrosinase modulation by five Rwandese herbal medicines traditionally used for skin treatment.
|
|
670
|
|
|
‡a
Author's Tyrosinase related protein 1 (TYRP1/gp75) in human cutaneous melanoma
|
|
670
|
|
|
‡a
Author's Ultraviolet B sensitivity of peripheral lymphocytes as an independent risk factor for cutaneous melanoma
|
|
919
|
|
|
‡a
ultravioletbsensitivityofperipherallymphocytesasanindependentriskfactorforcutaneousmelanoma
‡A
Ultraviolet B sensitivity of peripheral lymphocytes as an independent risk factor for cutaneous melanoma
‡9
1
|
|
919
|
|
|
‡a
tyrosinaserelatedprotein1tyrp1gp75inhumancutaneousmelanoma
‡A
Tyrosinase related protein 1 (TYRP1/gp75) in human cutaneous melanoma
‡9
1
|
|
919
|
|
|
‡a
tumourtargetingandradiationdoseofradioimmunotherapywith90yrituximabincd20+bcelllymphomaaspredictedby89zrrituximabimmunopetimpactofpreloadingwithunlabelledrituximab
‡A
Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab
‡9
1
|
|
919
|
|
|
‡a
toadvenomantiproliferativeactivitiesonmetastaticmelanomabioguidedfractionationandscreeningofthecompoundsof2differentvenoms
‡A
Toad Venom Antiproliferative Activities on Metastatic Melanoma: Bio-Guided Fractionation and Screening of the Compounds of Two Different Venoms
‡9
1
|
|
919
|
|
|
‡a
srcinhibitordasatinibacceleratesthedifferentiationofhumanbonemarrowderivedmesenchymalstromalcellsintoosteoblasts
‡A
The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts
‡9
1
|
|
919
|
|
|
‡a
surveyonskinlighteningpracticesandcosmeticsinkigalirwanda
‡A
Survey on skin-lightening practices and cosmetics in Kigali, Rwanda
‡9
1
|
|
919
|
|
|
‡a
signalingfromthehumanmelanocortin1receptortoerk1anderk2mitogenactivatedproteinkinasesinvolvestransactivationofckit
‡A
Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT.
‡9
1
|
|
919
|
|
|
‡a
sequentialuseofproteinkinaseinhibitorspotentiatestheirtoxicitytomelanomacellsarationaletocombinetargeteddrugsbasedonproteinexpressioninhibitionprofiles
‡A
Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: a rationale to combine targeted drugs based on protein expression inhibition profiles
‡9
1
|
|
919
|
|
|
‡a
roleofmacrophagemigrationinhibitoryfactormifinmelanoma
‡A
Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma
‡9
1
|
|
919
|
|
|
‡a
roleoffarnesoid10receptor
‡A
Role of farnesoid X receptor
‡9
1
|
|
919
|
|
|
‡a
robustgeneexpressionprogramsunderlierecurrentcellstatesandphenotypeswitchinginmelanoma
‡A
Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma
‡9
1
|
|
919
|
|
|
‡a
prominentroleofcyclicadenosinemonophosphatesignallingpathwayinthesensitivityofwtbrafwtnrasmelanomacellstovemurafenib
‡A
Prominent role of cyclic adenosine monophosphate signalling pathway in the sensitivity of (WT)BRAF/(WT)NRAS melanoma cells to vemurafenib.
‡9
1
|
|
919
|
|
|
‡a
prima1andprima1metapr246frommutantwildtypep53reactivationtounexpectedmechanismsunderlyingtheirpotentantitumoreffectincombinatorialtherapies
‡A
PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies
‡9
1
|
|
919
|
|
|
‡a
prima1andprima1met
‡A
PRIMA-1 and PRIMA-1Met
‡9
1
|
|
919
|
|
|
‡a
pharmacologicalinhibitionofmacrophagemigrationinhibitoryfactorinterfereswiththeproliferationandinvasivenessofsquamouscarcinomacells
‡A
Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells
‡9
1
|
|
919
|
|
|
‡a
pericytelikelocationofgfptaggedmelanomacellsexvivoandinvivostudiesofextravascularmigratorymetastasis
‡A
Pericyte-like location of GFP-tagged melanoma cells: ex vivo and in vivo studies of extravascular migratory metastasis
‡9
1
|
|
919
|
|
|
‡a
p53reactivationbyprima1metapr246sensitisesv600ekbrafmelanomatovemurafenib
‡A
p53 Reactivation by PRIMA-1(Met) (APR-246) sensitises (V600E/K)BRAF melanoma to vemurafenib.
‡9
1
|
|
919
|
|
|
‡a
overexpressionofmalignancyassociatedlamininsandlamininreceptorsbyangiotropichumanmelanomacellsinachickchorioallantoicmembranemodel
‡A
Overexpression of malignancy-associated laminins and laminin receptors by angiotropic human melanoma cells in a chick chorioallantoic membrane model
‡9
1
|
|
919
|
|
|
‡a
newdrugcombinationstrategiesinmelanomacurrentstatusandfuturedirections
‡A
New Drug Combination Strategies in Melanoma: Current Status and Future Directions.
‡9
1
|
|
919
|
|
|
‡a
nacetylcysteinebreaksresistancetotrastuzumabcausedbymuc4overexpressioninhumanher2positivebcbearingnudemicemonitoredby89zrtrastuzumaband18ffdgpetimaging
‡A
N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by 89Zr-Trastuzumab and 18F-FDG PET imaging
‡9
1
|
|
919
|
|
|
‡a
multimodalityimagingcanpredictthemetabolicresponseofunresectablecolorectallivermetastasestoradioembolizationtherapywithyttrium90labeledresinmicrospheres
‡A
Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres
‡9
1
|
|
919
|
|
|
‡a
melanomacellattachmentinvasionandintegrinexpressionisupregulatedbytumornecrosisfactoralphaandsuppressedbyalphamelanocytestimulatinghormone
‡A
Melanoma cell attachment, invasion, and integrin expression is upregulated by tumor necrosis factor alpha and suppressed by alpha melanocyte stimulating hormone
‡9
1
|
|
919
|
|
|
‡a
melaninsandmelanogenesisfrompigmentcellstohumanhealthandtechnologicalapplications
‡A
Melanins and melanogenesis: from pigment cells to human health and technological applications
‡9
1
|
|
919
|
|
|
‡a
prominentroleofcyclicadenosinemonophosphatesignallingpathwayinthesensitivityof
‡A
Prominent role of cyclic adenosine monophosphate signalling pathway in the sensitivity of
‡9
1
|
|
919
|
|
|
‡a
mdm4isakeytherapeutictargetincutaneousmelanoma
‡A
MDM4 is a key therapeutic target in cutaneous melanoma
‡9
1
|
|
919
|
|
|
‡a
imagingoftumourinducedosteomalaciausingagallium68labelledsomatostatinanalogue
‡A
Imaging of tumour-induced osteomalacia using a gallium-68 labelled somatostatin analogue.
‡9
1
|
|
919
|
|
|
‡a
hypopigmentingagentsanupdatedreviewonbiologicalchemicalandclinicalaspects
‡A
Hypopigmenting agents: an updated review on biological, chemical and clinical aspects
‡9
1
|
|
919
|
|
|
‡a
roleoffarnesoid10receptorfxrintheprocessofdifferentiationofbonemarrowstromalcellsintoosteoblasts
‡A
Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts
‡9
1
|
|
919
|
|
|
‡a
humanmelanomacellmigrationalongcapillarylikestructuresinvitroanewdynamicmodelforstudyingextravascularmigratorymetastasis
‡A
Human melanoma cell migration along capillary-like structures in vitro: a new dynamic model for studying extravascular migratory metastasis
‡9
1
|
|
919
|
|
|
‡a
her4anditscytoplasmicisoformsareassociatedwithprogressionfreesurvivalofmalignantmelanoma
‡A
HER4 and its cytoplasmic isoforms are associated with progression-free survival of malignant melanoma.
‡9
1
|
|
919
|
|
|
‡a
hasremovalofexcesscysteineledtotheevolutionofpheomelanin
‡A
Has removal of excess cysteine led to the evolution of pheomelanin?
‡9
1
|
|
919
|
|
|
‡a
inhibitorgant61killsmelanomacellsandactsinsynergywithobatoclax
‡A
GLI inhibitor GANT61 kills melanoma cells and acts in synergy with obatoclax.
‡9
1
|
|
919
|
|
|
‡a
functionalstatusandrelationshipsofmelanocortin1receptorsignalingtothecampandextracellularsignalregulatedproteinkinases1and2pathwaysinhumanmelanomacells
‡A
Functional status and relationships of melanocortin 1 receptor signaling to the cAMP and extracellular signal-regulated protein kinases 1 and 2 pathways in human melanoma cells.
‡9
1
|
|
919
|
|
|
‡a
evaluationoftheserum50dopa50tyrosineratioasamelanomamarker
‡A
Evaluation of the serum L-dopa/L-tyrosine ratio as a melanoma marker
‡9
1
|
|
919
|
|
|
‡a
eortcmelanomagroupachievements
‡A
EORTC Melanoma Group achievements
‡9
1
|
|
919
|
|
|
‡a
tyrosinasemodulationby5rwandeseherbalmedicinestraditionallyusedforskintreatment
‡A
Tyrosinase modulation by five Rwandese herbal medicines traditionally used for skin treatment.
‡9
1
|
|
919
|
|
|
‡a
chronicexposuretolowdoseradiationatchernobylfavoursadaptationtooxidativestressinbirds
‡A
Chronic exposure to low-dose radiation at Chernobyl favours adaptation to oxidative stress in birds
‡9
1
|
|
919
|
|
|
‡a
therapeuticapproachtoperianalextramammarypagetsdiseasetopicalimiquimodcanbeusefultopreventordefersurgery
‡A
A therapeutic approach to perianal extramammary Paget's disease: topical imiquimod can be useful to prevent or defer surgery
‡9
1
|
|
919
|
|
|
‡a
noncodingfunctionoftyrp1mrnapromotesmelanomagrowth
‡A
A non-coding function of TYRP1 mRNA promotes melanoma growth.
‡9
1
|
|
996
|
|
|
‡2
LC|n 99900007
|
|
996
|
|
|
‡2
SUDOC|188382852
|
|
996
|
|
|
‡2
SUDOC|203531981
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
